Page last updated: 2024-08-23

bisantrene and Colonic Neoplasms

bisantrene has been researched along with Colonic Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Marco, C; Folini, M; Palumbo, M; Pivetta, C; Sissi, C; Zaffaroni, N; Zagotto, G1
Ahmed, T; Harper, HD; Kemeny, NE; Michaelson, RA1
Kovach, JS; Powis, G1
Barlogie, B; Drewinko, B; Trujillo, JM; Yang, LY1
Hahn, RG; Jones, AR; Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J1
Anbar, D; Forastiere, AA; Perry, MC; Richards, F; Weiss, RB1
Annable, T; Arceci, RJ; Collins, KI; Durr, FE; Greenberger, LM; Ho, JP; Ritke, MK; Slovak, ML; Yalowich, JC; Zhang, XP1

Other Studies

7 other study(ies) available for bisantrene and Colonic Neoplasms

ArticleYear
Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
    Biochemical pharmacology, 2010, Jun-15, Volume: 79, Issue:12

    Topics: Anthracenes; Antibiotics, Antineoplastic; Cell Line, Tumor; Colonic Neoplasms; G-Quadruplexes; Humans; Inhibitory Concentration 50; Isomerism; Melanoma; Molecular Structure; Nucleic Acid Denaturation; Osteosarcoma; Structure-Activity Relationship; Taq Polymerase; Telomerase; Telomere

2010
Phase II trial of bisantrene in advanced colorectal carcinoma.
    Cancer treatment reports, 1983, Volume: 67, Issue:3

    Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms

1983
Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
    Cancer research, 1983, Volume: 43, Issue:2

    Topics: Animals; Anthracenes; Colonic Neoplasms; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Phlebitis; Rabbits; Rectal Neoplasms; Urinary Bladder Neoplasms

1983
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro.
    Cancer research, 1983, Volume: 43, Issue:6

    Topics: Anthracenes; Anthraquinones; Cell Line; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Humans; Mitoxantrone; Time Factors

1983
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
    American journal of clinical oncology, 1983, Volume: 6, Issue:4

    Topics: Adenocarcinoma; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms

1983
Phase II trial of bisantrene in advanced colorectal cancer: a cancer and leukemia group B study.
    Cancer treatment reports, 1982, Volume: 66, Issue:11

    Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Rectal Neoplasms

1982
P-glycoprotein mediates profound resistance to bisantrene.
    Oncology research, 1994, Volume: 6, Issue:7

    Topics: Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chromosome Banding; Chromosomes, Human; Clone Cells; Colonic Neoplasms; DNA Primers; Drug Resistance, Multiple; Humans; In Situ Hybridization, Fluorescence; KB Cells; Melanoma; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Transfection; Tumor Cells, Cultured

1994